Market Cap 143.73B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.95
Forward PE 8.58
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 42,977,300
Avg Vol 68,765,250
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 39%
Beta 0.47
Analysts Sell
Price Target $27.95

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
barnml2006
barnml2006 Jan. 9 at 1:54 PM
$PFE I'm predicting a close of $25.50 +/- .15 Green day but not by much. Thoughts?
0 · Reply
taxplanr
taxplanr Jan. 9 at 1:29 PM
He got bladder cancer in 2022. Isn't that odd timing? $BNTX $MRNA $PFE https://trendingpoliticsnews.com/the-middle-star-passes-away-at-60-trin/?utm_source=DS21
0 · Reply
Jack90
Jack90 Jan. 9 at 1:26 PM
$PFE need a deal with OpenAI to spike stock like $OKLO $VST $INTC and $SNDK
0 · Reply
Alexandre_300
Alexandre_300 Jan. 9 at 1:22 PM
$ALT Madrigal licenses Pfizer’s DGAT-2 inhibitor to expand MASH pipeline $ALT 👀 $PFE
0 · Reply
Jack90
Jack90 Jan. 9 at 1:18 PM
Dump $OKLO adding $PFE OKLO never make a penny revenue yet
0 · Reply
Ladd220
Ladd220 Jan. 9 at 12:14 PM
$PFE My once a quarter positive Pfizer post. Might be frustrating the price doesn’t really move. However if you have been holding awhile go back and look at your dividends received. I bought 4k shares in December of 2023 at $26 a share. Since then I have been paid out $20K even though the share price is the same if this hits $35 or $40 in a year the return will well be worth it. Patience my friends!
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 5:56 AM
$PFE Share Price: $25.27 Contract Selected: Jan 30, 2026 $25 Calls Buy Zone: $0.48 – $0.60 Target Zone: $0.80 – $0.98 Potential Upside: 57% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
taxplanr
taxplanr Jan. 9 at 3:04 AM
What will $BNTX $MRNA $PFE and friends thin of next? https://anamihalceamdphd.substack.com/p/government-assurances-of-biotech?utm_source=post-email-title&publication_id=956088&post_id=183965336&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 9 at 2:07 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: JAN 30 2026 Buy in Price: $0.23 - $0.24 Sell Price: $0.37 Profit : +63% (Turn every $1 into $1.63) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Crypto9999
Crypto9999 Jan. 8 at 11:52 PM
$PFE In the spirit of M& Recent article: Big Pharma race to snap up biotech assets as $170 billion patent cliff looms... Less than 6 million shares in the float, a healthy patent repository... KRRO is poised(imo) for a massive run...
0 · Reply
Latest News on PFE
Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 2 days ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK


Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 6 days ago

Pfizer 2026: The Reset Year


Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 20 days ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound


Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 22 days ago

Pfizer Stock Can Sink More. Here Is How


Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 23 days ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript


Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 23 days ago

Pfizer falls on disappointing guidance


Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 24 days ago

Here's why Pfizer is revising its revenue forecasts


Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 27 days ago

Pfizer Declares First-Quarter 2026 Dividend


Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 5 weeks ago

Pfizer: The Market Is Still Wrong About It


Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Nov 30, 2025, 6:13 AM EST - 5 weeks ago

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters


barnml2006
barnml2006 Jan. 9 at 1:54 PM
$PFE I'm predicting a close of $25.50 +/- .15 Green day but not by much. Thoughts?
0 · Reply
taxplanr
taxplanr Jan. 9 at 1:29 PM
He got bladder cancer in 2022. Isn't that odd timing? $BNTX $MRNA $PFE https://trendingpoliticsnews.com/the-middle-star-passes-away-at-60-trin/?utm_source=DS21
0 · Reply
Jack90
Jack90 Jan. 9 at 1:26 PM
$PFE need a deal with OpenAI to spike stock like $OKLO $VST $INTC and $SNDK
0 · Reply
Alexandre_300
Alexandre_300 Jan. 9 at 1:22 PM
$ALT Madrigal licenses Pfizer’s DGAT-2 inhibitor to expand MASH pipeline $ALT 👀 $PFE
0 · Reply
Jack90
Jack90 Jan. 9 at 1:18 PM
Dump $OKLO adding $PFE OKLO never make a penny revenue yet
0 · Reply
Ladd220
Ladd220 Jan. 9 at 12:14 PM
$PFE My once a quarter positive Pfizer post. Might be frustrating the price doesn’t really move. However if you have been holding awhile go back and look at your dividends received. I bought 4k shares in December of 2023 at $26 a share. Since then I have been paid out $20K even though the share price is the same if this hits $35 or $40 in a year the return will well be worth it. Patience my friends!
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 9 at 5:56 AM
$PFE Share Price: $25.27 Contract Selected: Jan 30, 2026 $25 Calls Buy Zone: $0.48 – $0.60 Target Zone: $0.80 – $0.98 Potential Upside: 57% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
taxplanr
taxplanr Jan. 9 at 3:04 AM
What will $BNTX $MRNA $PFE and friends thin of next? https://anamihalceamdphd.substack.com/p/government-assurances-of-biotech?utm_source=post-email-title&publication_id=956088&post_id=183965336&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 9 at 2:07 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: JAN 30 2026 Buy in Price: $0.23 - $0.24 Sell Price: $0.37 Profit : +63% (Turn every $1 into $1.63) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Crypto9999
Crypto9999 Jan. 8 at 11:52 PM
$PFE In the spirit of M& Recent article: Big Pharma race to snap up biotech assets as $170 billion patent cliff looms... Less than 6 million shares in the float, a healthy patent repository... KRRO is poised(imo) for a massive run...
0 · Reply
Willieberich
Willieberich Jan. 8 at 11:19 PM
$PFE this is 1 of the few stocks that are actually reacting rationally to its p/e and forward earnings .should be at the very least $30 . They can't suppress the price for to long .
2 · Reply
barnml2006
barnml2006 Jan. 8 at 9:18 PM
$PFE well most Fridays close green for #pfe so tomorrow we might stay the same price as today's closing.
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 8 at 8:58 PM
$PFE fuck sake just let it close green
0 · Reply
Moonman321
Moonman321 Jan. 8 at 8:49 PM
$CABA $NVDA $PFEThis isn’t the first time this stock has done this. Before the run to 26, the setup was the same: a long rounded cup followed by a frustrating handle that convinced everyone it was dead. Price went nowhere, sentiment turned bearish, and people got shaken out right before the move. That prior run didn’t start on good news. It started after months of basing, tightening, and boredom. That’s exactly what’s happening again. The cup is already formed. The current consolidation is the handle — shallow pullback, tightening range, support holding. That’s digestion, not weakness. Same structure. Same psychology. Same frustration phase. Last time, once the handle resolved, price didn’t drift higher — it launched. Cup-and-handle breakouts don’t happen when everyone’s ready. They happen when most people are tired of waiting. You’re welcome!
1 · Reply
Moonman321
Moonman321 Jan. 8 at 8:42 PM
$CABA $PFE $NVDA What we have here is an autoimmune  cure !!!  What’s developing here looks like a cup-and-handle, once you separate structure from noise. The cup formed over months with a rounded base and a steady right-side recovery back toward resistance. That’s exactly how proper cups are built — slow, controlled, and boring. The brief move to 3.67 was a news-driven spike that temporarily distorted the rim, but it doesn’t invalidate the pattern. Ignore the spike and the true rim sits around 2.5–2.7. Since then, price has been working through the handle: • Pullback is shallow • Lows are holding above the base (~2.0–2.1) • Volatility is contracting • Selling pressure is being absorbed That’s what healthy handles do — they shake out late buyers and tighten before the next move. A cup-and-handle doesn’t break out on headlines. It breaks out after digestion. The pattern completes on a reclaim of ~2.6–2.8 with volume. Until then, this is normal handle behavior, not failure.
0 · Reply
reyofhope
reyofhope Jan. 8 at 8:33 PM
$PFE big al will deliver . Believe everyone.
0 · Reply
1hawk
1hawk Jan. 8 at 8:23 PM
$PFE added 26 shares
0 · Reply
barnml2006
barnml2006 Jan. 8 at 8:17 PM
$PFE called it.. more waiting.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Jan. 8 at 8:16 PM
$PFE The good news is that its doing exactly what we all knew it would
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 8 at 8:00 PM
$PFE fuck right off…
0 · Reply
A_Train1
A_Train1 Jan. 8 at 7:58 PM
$PFE SPECIAL COMPENSATION PROPOSAL: PFE shareholders that have held this stock for more than a year should receive a special dividend for the pain and suffering associated with being a long-term shareholder. If this were a court of law, we would absolutely get additional payment for the misery caused by the situation.
0 · Reply
Tiger65
Tiger65 Jan. 8 at 7:52 PM
$PFE Pfizer shareholders deserve a real doc, not a vet!
1 · Reply